119 related articles for article (PubMed ID: 38224012)
1. The HIF-1α/PKM2 Feedback Loop in Relation to EGFR Mutational Status in Lung Adenocarcinoma.
Wang Y; Lian H; Li J; Zhao M; Hao Z; Zheng X; Zhao L; Cui J
J Invest Surg; 2024 Dec; 37(1):2301081. PubMed ID: 38224012
[TBL] [Abstract][Full Text] [Related]
2. The transcription factor TEAD4 enhances lung adenocarcinoma progression through enhancing PKM2 mediated glycolysis.
Hu Y; Mu H; Deng Z
Cell Biol Int; 2021 Oct; 45(10):2063-2073. PubMed ID: 34196069
[TBL] [Abstract][Full Text] [Related]
3. LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma.
Chen Z; Hu Z; Sui Q; Huang Y; Zhao M; Li M; Liang J; Lu T; Zhan C; Lin Z; Sun F; Wang Q; Tan L
Int J Biol Sci; 2022; 18(2):522-535. PubMed ID: 35002507
[No Abstract] [Full Text] [Related]
4. Expression of HIF-1α/PKM2 axis correlates to biological and clinical significance in papillary thyroid carcinoma.
Hao Z; Wang Y; Li J; Liu W; Zhao W; Wang J
Medicine (Baltimore); 2023 Mar; 102(10):e33232. PubMed ID: 36897686
[TBL] [Abstract][Full Text] [Related]
5. Functional cooperation between HIF-1α and c-Jun in mediating primary and acquired resistance to gefitinib in NSCLC cells with activating mutation of EGFR.
Meng S; Wang G; Lu Y; Fan Z
Lung Cancer; 2018 Jul; 121():82-90. PubMed ID: 29858032
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis.
Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G
Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748
[No Abstract] [Full Text] [Related]
7. Hypoxia-inducible factor-1α and nuclear factor-κB play important roles in regulating programmed cell death ligand 1 expression by epidermal growth factor receptor mutants in non-small-cell lung cancer cells.
Guo R; Li Y; Wang Z; Bai H; Duan J; Wang S; Wang L; Wang J
Cancer Sci; 2019 May; 110(5):1665-1675. PubMed ID: 30844110
[TBL] [Abstract][Full Text] [Related]
8. HIF-1α promoted vasculogenic mimicry formation in lung adenocarcinoma through NRP1 upregulation in the hypoxic tumor microenvironment.
Fu R; Du W; Ding Z; Wang Y; Li Y; Zhu J; Zeng Y; Zheng Y; Liu Z; Huang JA
Cell Death Dis; 2021 Apr; 12(4):394. PubMed ID: 33850110
[TBL] [Abstract][Full Text] [Related]
9. The impact of PRDX4 and the EGFR mutation status on cellular proliferation in lung adenocarcinoma.
Mizutani K; Guo X; Shioya A; Zhang J; Zheng J; Kurose N; Ishibashi H; Motono N; Uramoto H; Yamada S
Int J Med Sci; 2019; 16(9):1199-1206. PubMed ID: 31588184
[No Abstract] [Full Text] [Related]
10. Calycosin Inhibits the Malignant Behaviors of Lung Adenocarcinoma Cells by Regulating the circ_0001946/miR-21/GPD1L/HIF-1
Zhou L; Chen W; Yang H; Liu J; Meng H
Dis Markers; 2022; 2022():3969389. PubMed ID: 35996717
[TBL] [Abstract][Full Text] [Related]
11. [Clinical research on the expression of three vascular regulatory factors in different morphological regions of Marjolin ulcer and their relationship with angiogenesis].
Xia C; Chu ZG
Zhonghua Shao Shang Za Zhi; 2019 Sep; 35(9):676-682. PubMed ID: 31594186
[No Abstract] [Full Text] [Related]
12. Responses of cancer cells with wild-type or tyrosine kinase domain-mutated epidermal growth factor receptor (EGFR) to EGFR-targeted therapy are linked to downregulation of hypoxia-inducible factor-1alpha.
Lu Y; Liang K; Li X; Fan Z
Mol Cancer; 2007 Oct; 6():63. PubMed ID: 17931419
[TBL] [Abstract][Full Text] [Related]
13. High expression of hypoxia inducible factor 1α related with acquired resistant to EGFR tyrosine kinase inhibitors in NSCLC.
Jin Q; Huang F; Xu X; He H; Zhang Y
Sci Rep; 2021 Jan; 11(1):1199. PubMed ID: 33441708
[TBL] [Abstract][Full Text] [Related]
14. The long noncoding RNA HOXA11-AS promotes lung adenocarcinoma proliferation and glycolysis via the microRNA-148b-3p/PKM2 axis.
Chen W; Li X; Du B; Cui Y; Ma Y; Li Y
Cancer Med; 2023 Feb; 12(4):4421-4433. PubMed ID: 35924724
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA P4HB promotes glycolysis and tumor progression by binding with PKM2 in lung adenocarcinoma.
Li H; Guo H; Huang Q; Wang S; Li X; Qiu M
Respir Res; 2023 Oct; 24(1):252. PubMed ID: 37880717
[TBL] [Abstract][Full Text] [Related]
16. HIF-1α is positively associated with endometrial receptivity by regulating PKM2.
Liang L; Yang Y; Yang L; Zhang X; Xu S; Liu Y; Wu X; Chao L
J Obstet Gynaecol Res; 2023 Nov; 49(11):2734-2745. PubMed ID: 37533344
[TBL] [Abstract][Full Text] [Related]
17. YY1-induced upregulation of LncRNA-ARAP1-AS2 and ARAP1 promotes diabetic kidney fibrosis
Li X; Ma TK; Wang M; Zhang XD; Liu TY; Liu Y; Huang ZH; Zhu YH; Zhang S; Yin L; Xu YY; Ding H; Liu C; Shi H; Fan QL
Front Pharmacol; 2023; 14():1069348. PubMed ID: 36874012
[No Abstract] [Full Text] [Related]
18. Altered Regulation of HIF-1α in Naive- and Drug-Resistant EGFR-Mutant NSCLC: Implications for a Vascular Endothelial Growth Factor-Dependent Phenotype.
Nilsson MB; Robichaux J; Herynk MH; Cascone T; Le X; Elamin Y; Patel S; Zhang F; Xu L; Hu L; Diao L; Shen L; He J; Yu X; Nikolinakos P; Saintigny P; Fang B; Girard L; Wang J; Minna JD; Wistuba II; Heymach JV
J Thorac Oncol; 2021 Mar; 16(3):439-451. PubMed ID: 33309987
[TBL] [Abstract][Full Text] [Related]
19. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture.
Dong T; Yan Y; Chai H; Chen S; Xiong X; Sun D; Yu Y; Deng L; Cheng F
Biomed Pharmacother; 2015 Feb; 69():277-84. PubMed ID: 25661370
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α promotes inflammatory response of chronic obstructive pulmonary disease by activating EGFR/PI3K/AKT pathway.
Zhang HX; Yang JJ; Zhang SA; Zhang SM; Wang JX; Xu ZY; Lin RY
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):6077-6084. PubMed ID: 30280794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
